{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:24:29Z","timestamp":1772677469105,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Juvenile Dermatomyositis (JDM) is the leading cause of non-infectious inflammatory myopathy in children. It is a heterogeneous group of autoimmune diseases characterized by a variable combination of muscular, dermatological, and visceral involvement. Myositis-specific autoantibodies help define homogeneous subgroups with common clinical characteristics and prognoses. Anti-SAE (small ubiquitin-like modifier 1 (SUMO-1) activating enzyme) antibodies are among the most recently discovered specific autoantibodies. The presence of these antibodies is very rare, making it challenging to define clinical features and prognosis in the juvenile form. We report the first case of an African patient with juvenile dermatomyositis and positive anti-SAE antibodies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case Report<\/jats:title>\n                <jats:p>A 5-year-3-month-old Moroccan boy presented to the pediatric emergency department with dysphagia that had been evolving for two days, preceded two months earlier by facial erythema associated with fatigue, lower limb pain, difficulty walking, and progressive inflammatory polyarthralgia. On admission, the child had a heliotrope rash with predominant pseudo-angioedema on the lips, periungual telangiectasia, and Gottron\u2019s papules over the bilateral interphalangeal and metatarsophalangeal joints. The patient had a more pronounced proximal muscle weakness in the lower limbs. He had no urticaria, fever, arthritis, calcinosis, cutaneous ulcers, or lipodystrophy. The Joint examination was normal, as was the pleuropulmonary examination. The electroneuromyography showed myogenic changes in all four limbs. Laboratory findings showed elevated levels of creatine phosphokinase and lactate dehydrogenase and a mild inflammatory syndrome. The electrocardiogram was normal. The anti-SAE antibodies were positive. The boy was diagnosed with juvenile dermatomyositis. He received methylprednisolone bolus therapy followed by oral prednisone. The latter was gradually tapered in combination with weekly intramuscular methotrexate. As a result, dysphagia disappeared within 48\u00a0h. After two weeks, there was an improvement in the muscular score and a significant regression of facial pseudo-angioedema.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report the first African patient with anti-SAE autoantibody-positive JDM. He had a typical dermatological manifestation of JDM associated with pseudo-angioedema predominant on the lips; a rarely reported sign in DM and JDM patients. The patient responded well to corticosteroid therapy and methotrexate.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00921-9","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:02:06Z","timestamp":1716274926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Khalila","family":"Nainia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Amine","family":"Aouzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Ouafik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariyam","family":"Charhbili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Bouchhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellatif","family":"Daoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Tizki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radia","family":"Chakiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"921_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","volume":"34","author":"DP Symmons","year":"1995","unstructured":"Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol. 1995;34:732.","journal-title":"Br J Rheumatol"},{"key":"921_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R, et al. US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49:300.","journal-title":"Arthritis Rheum"},{"key":"921_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","volume":"360","author":"JM Gardner-Medwin","year":"2002","unstructured":"Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki Disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197.","journal-title":"Lancet"},{"key":"921_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/bjd.18799","volume":"182","author":"C Moegle","year":"2020","unstructured":"Moegle C, Severac F, Lipsker D. Epidemiology of juvenile dermatomyositis in Alsace. Br J Dermatol. 2020;182:1307.","journal-title":"Br J Dermatol"},{"key":"921_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","volume":"148","author":"LM Pachman","year":"2006","unstructured":"Pachman LM, Abbott K, Sinacore JM, et al. Duration of Illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr. 2006;148:247.","journal-title":"J Pediatr"},{"key":"921_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/BOR.0000000000000224","volume":"27","author":"S Tansley","year":"2015","unstructured":"Tansley S, Wedderburn LR. Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes. Curr Opin Rheumatol. 2015;27:601\u20137. [PubMed: 26352731].","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"921_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK caucasian adult-onset myositis. Ann Rheum Dis. 2009;68(10):1621\u20135. https:\/\/doi.org\/10.1136\/ard.2008.097162.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"921_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280(1):8\u201323. https:\/\/doi.org\/10.1111\/joim.12451.","journal-title":"J Intern Med"},{"issue":"2","key":"921_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020;82(2):267\u201381. https:\/\/doi.org\/10.1 016\/j.jaad.2019.06.1309.","journal-title":"J Am Acad Dermatol"},{"key":"921_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G, Betteridge ZE, Almeida B, Gunawardena H, Thomson W, Beresford MW, Midgley A, Muntoni F, Wedderburn LR, McHugh NJ. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017;84:55\u201364. Epub 2017 Jun 26. PMID: 28663002; PMCID: PMC5656106.","journal-title":"J Autoimmun"},{"issue":"11","key":"921_CR11","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","volume":"68","author":"CT Deakin","year":"2016","unstructured":"Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, McHugh NJ, Varsani H, Holton JL, Jacques TS, Pilkington CA, Nistala K, Wedderburn LR, UK Juvenile Dermatomyositis Research Group. Muscle biopsy findings in Combination with Myositis-Specific autoantibodies Aid Prediction of outcomes in Juvenile Dermatomyositis. Arthritis Rheumatol. 2016;68(11):2806\u201316. Epub 2016 Oct 9. PMID: 27214289; PMCID: PMC5091622.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"921_CR12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European league against rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.","journal-title":"Ann Rheum Dis"},{"key":"921_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","volume":"195","author":"LM Pachman","year":"2018","unstructured":"Pachman LM, Khojah AM. Advances in Juvenile Dermatomyositis: Myositis specific antibodies aid in understanding Disease Heterogeneity. J Pediatr. 2018;195:16\u201327. https:\/\/doi.org\/10.1016\/j.jpeds.2017.12.053. PMID: 29576174; PMCID: PMC5881602.","journal-title":"J Pediatr"},{"key":"921_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G, Betteridge ZE, Almeida B, Gunawardena H, et al. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017;84:55\u201364.","journal-title":"J Autoimmun"},{"key":"921_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2017.12.053","volume":"195","author":"LM Pachman","year":"2018","unstructured":"Pachman LM, Khojah AM. Advances in juvenile dermatomyositis: myositis specifc antibodies aid in understanding Disease heterogeneity. J Pediatr. 2018;195:16\u201327.","journal-title":"J Pediatr"},{"issue":"5","key":"921_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00296-017-3707-4","volume":"37","author":"A Hussain","year":"2017","unstructured":"Hussain A, Rawat A, Jindal AK, Gupta A, Singh S. Autoantibodies in children with juvenile dermatomyositis: a single centre experience from North-West India. Rheumatol Int. 2017;37(5):807\u201312.","journal-title":"Rheumatol Int"},{"issue":"1","key":"921_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12026-022-09334-4","volume":"71","author":"P Vignesh","year":"2023","unstructured":"Vignesh P, Barman P, Basu S, Mondal S, Ishran B, Kumrah R, Dod A, Garg R, Rawat A, Singh S. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature. Immunol Res. 2023;71(1):112\u201320. https:\/\/doi.org\/10.1007\/s12026-022-09334-4. Epub 2022 Oct 24. PMID: 36278969.","journal-title":"Immunol Res"},{"key":"921_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41598-017-00240-6","volume":"7","author":"Y Ge","year":"2017","unstructured":"Ge Y, Lu X, Shu X, Peng Q, Wang G. Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with diferent patient cohorts. Sci Rep. 2017;7:188.","journal-title":"Sci Rep"},{"key":"921_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semarthrit.2014.04.004","volume":"44","author":"JC Milisenda","year":"2014","unstructured":"Milisenda JC, Doti PI, Prieto-Gonz\u00e1lez S, et al. Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature. Semin Arthritis Rheum. 2014;44:228\u201333. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.04.004. [PMID: 24830790].","journal-title":"Semin Arthritis Rheum"},{"key":"921_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic infammatory myopathy patients. J Autoimmun. 2019;101:48\u201355.","journal-title":"J Autoimmun"},{"issue":"1","key":"921_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","volume":"72","author":"M Fujimoto","year":"2013","unstructured":"Fujimoto M, Matsushita T, Hamaguchi Y, Kaji K, Asano Y, Ogawa F, et al. Autoantibodies to small ubiquitin-like modifer activating enzymes in Japanese patients with dermatomyositis: comparison with a UK caucasian cohort. Ann Rheum Dis. 2013;72(1):151\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"921_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","volume":"384","author":"E Tarricone","year":"2012","unstructured":"Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE antibodies in autoimmune myositis: identifcation by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods. 2012;384(1\u20132):128\u201334.","journal-title":"J Immunol Methods"},{"issue":"6","key":"921_CR23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.25251\/skin.4.6.15","volume":"4","author":"C Wilson","year":"2020","unstructured":"Wilson C, Roman B, Ashack K, Aronson IK. Anti-SAE1 antibodies and dermatomyositis: a case series of three patients. SKIN J Cutan Med. 2020;4(6):578\u201384.","journal-title":"SKIN J Cutan Med"},{"issue":"9","key":"921_CR24","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/rheumatology\/kev247","volume":"54","author":"Y Muro","year":"2015","unstructured":"Muro Y, Sugiura K, Nara M, Sakamoto I, Suzuki N, Akiyama M. High incidence of cancer in anti-small ubiquitin-like modifer activating enzyme antibody-positive dermatomyositis. Rheumatol. 2015;54(9):1745\u20137.","journal-title":"Rheumatol"},{"issue":"12","key":"921_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6ll\u0151si L, Dank\u00f3 K. Four dermatomyositis-specifc autoantibodies-antiTIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic infammatory myopathies in a Hungarian cohort. Autoimmun Rev. 2014;13(12):1211\u20139.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"921_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/acr2.11247","volume":"3","author":"J Albayda","year":"2021","unstructured":"Albayda J, Mecoli C, Casciola-Rosen L, Danof SK, Lin CT, Hines D, et al. A north American cohort of anti-SAE dermatomyositis: clinical phenotype, testing, and review of cases. ACR Open Rheumatol. 2021;3(5):287\u201394.","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"921_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000445835","volume":"169","author":"MF Andersen","year":"2016","unstructured":"Andersen MF, Longhurst HJ, Rasmussen ER, Bygum A. How not to be misled by disorders mimicking Angioedema: a review of Pseudoangioedema. Int Arch Allergy Immunol. 2016;169(3):163\u201370. https:\/\/doi.org\/10.1159\/000445835. Epub 2016 Apr 22. PMID: 27100932.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"921_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","volume":"53","author":"C Mainetti","year":"2017","unstructured":"Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous manifestations of dermatomyositis: a comprehensive review. Clin Rev Allergy Immunol. 2017;53(3):337\u201356. https:\/\/doi.org\/10.1007\/s12016-017-8652-1.","journal-title":"Clin Rev Allergy Immunol"},{"key":"921_CR29","doi-asserted-by":"crossref","unstructured":"Karaca \u00d6, G\u00fcng\u00f6r M, Sakarya G\u00fcne\u015f A, Eser \u015eim\u015fek I, An\u0131k Y, Kara B. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients. Int J Rheum Dis. 2022;25(5):617\u2013625. doi: 10.1111\/1756-185X.14311. Epub 2022 Mar 3. PMID: 35238477.","DOI":"10.1111\/1756-185X.14311"},{"issue":"12","key":"921_CR30","first-page":"966","volume":"58","author":"DM Li","year":"2020","unstructured":"Li DM, Wang L, Liu MY, Xu L, Tang XM. The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis. Zhonghua Er Ke Za Zhi. 2020;58(12):966\u201372. Chinese. 10.3760\/cma.j.cn112 140-20200724-00751.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"921_CR31","doi-asserted-by":"publisher","unstructured":"Werner de Castro GR, Appenzeller S, B\u00e9rtolo MB et al. Acute dermatomyositis with subcutaneous generalized edema. Clin Rheumatol. 2006; 25:898\u2013900. [PMID: 16308667] https:\/\/doi.org\/10.1007\/s10067-005-0053-9 antinuclear antibody, anti-SS-A\/Ro, anti-SS-B\/La, and anti-centromere antibodies, all positive.","DOI":"10.1007\/s10067-005-0053-9"},{"key":"921_CR32","doi-asserted-by":"publisher","unstructured":"Hall VC, Keeling JH, Davis MDP. Periorbital edema as the presenting sign of dermatomyositis. Int J Dermatol. 2003; 42:466-7. [PMID: 12786876] https:\/\/doi.org\/10.1046\/j.1365-4362. 2003.01696.","DOI":"10.1046\/j.1365-4362"},{"key":"921_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1525-1470.1999.99013","volume":"16","author":"GM Sevigny","year":"1999","unstructured":"Sevigny GM, Mathes BM. Periorbital edema as the presenting sign of juvenile dermatomyositis. Pediatr Dermatol. 1999;16:43\u20135. https:\/\/doi.org\/10.1046\/j.1525-1470.1999.99013. [PMID: 10027999].","journal-title":"Pediatr Dermatol"},{"key":"921_CR34","doi-asserted-by":"publisher","first-page":"e220641","DOI":"10.7326\/aimcc.2022.0641","volume":"2","author":"S Nuss","year":"2023","unstructured":"Nuss S, Spiegel K, Rumery KK. Dermatomyositis presenting as pseudo-angioedema. AIM Clin Cases. 2023;2:e220641. https:\/\/doi.org\/10.7326\/aimcc.2022.0641.","journal-title":"AIM Clin Cases"},{"issue":"2","key":"921_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76(2):329\u201340. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209247. Epub 2016 Aug 11. PMID: 27515057; PMCID: PMC5284351.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00921-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00921-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:06:50Z","timestamp":1716275210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00921-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00921-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"17 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Publication consent was obtained from the patient and her guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}